QIAGEN Company

Our journey began in the mid-1980s, the early days of biotechnology. As an entrepreneurial spin-off of university research, QIAGEN created a simpler, safer way for laboratories to handle the painstaking tasks of preparing samples to explore the mysteries of DNA. Since then, we have expanded across the continuum of molecular testing to establish QIAGEN as a global leader in rapidly growing fields of molecular diagnostics and life sciences.

Today some 4,700 QIAGEN employees, based in more than 25 countries, provide expertise and service to customers nearly everywhere. Our people share a collaborative, truly global culture – plus a commitment to making improvements in life possible.

As a public company listed on the New York Stock and Frankfurt Prime Standard exchanges, QIAGEN embraces transparency, accountability and good corporate governance.

QIAGEN is known to more than 500,000 customers around the world for our innovation, engagement, integrity, quality and passion. This identity creates relationships for our global team across the continuum from research in the life sciences, to molecular diagnostics and public safety applications in everyday use.

Our mission is to deliver Sample to Insight solutions enabling QIAGEN customers to unlock valuable molecular insights faster, better and more efficiently – from the raw biological sample to the final interpreted result. But Sample to Insight is more than just about providing smooth, end-to-end workflows. It's a strategic framework that puts the needs and challenges of our customers front and center. We want to identify key bottlenecks holding customers back and to deliver solutions so they can achieve greater success, ultimately helping them to exceed their own expectations.